CSPC Pharmaceutical Group Limited
CHJTF
$1.28
$0.0756.25%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -17.16% | -9.33% | -5.41% | -3.03% | -0.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.16% | -9.33% | -5.41% | -3.03% | -0.56% |
| Cost of Revenue | -8.26% | -7.74% | -6.82% | -5.77% | -3.61% |
| Gross Profit | -20.71% | -10.00% | -4.81% | -1.89% | 0.71% |
| SG&A Expenses | -23.90% | -7.35% | -6.54% | -9.69% | -7.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.24% | -4.89% | -4.61% | -4.56% | -1.81% |
| Operating Income | -34.12% | -24.82% | -8.28% | 2.54% | 4.02% |
| Income Before Tax | -31.32% | -25.77% | -15.91% | -4.16% | -3.55% |
| Income Tax Expenses | -22.96% | -7.31% | -1.66% | 8.39% | 2.63% |
| Earnings from Continuing Operations | -33.23% | -29.77% | -18.82% | -6.73% | -4.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 94.21% | 94.71% | 61.60% | 21.55% | -11.57% |
| Net Income | -31.46% | -27.57% | -17.51% | -6.31% | -5.27% |
| EBIT | -34.12% | -24.82% | -8.28% | 2.54% | 4.02% |
| EBITDA | -28.64% | -20.67% | -6.30% | 3.33% | 4.16% |
| EPS Basic | -30.39% | -27.04% | -17.12% | -5.84% | -4.67% |
| Normalized Basic EPS | -27.21% | -21.93% | -7.98% | 0.74% | 2.59% |
| EPS Diluted | -30.39% | -27.04% | -17.12% | -5.84% | -4.67% |
| Normalized Diluted EPS | -27.21% | -21.93% | -7.98% | 0.74% | 2.59% |
| Average Basic Shares Outstanding | -1.84% | -1.13% | -0.65% | -0.51% | -0.53% |
| Average Diluted Shares Outstanding | -1.86% | -1.15% | -0.68% | -0.50% | -0.52% |
| Dividend Per Share | -4.96% | -4.96% | 17.13% | 18.77% | 30.58% |
| Payout Ratio | -- | -- | -- | -- | -- |